Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAutolus Therapeutics plc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Autolus Therapeutics plc

$1.80Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $45.69M. Net result −$39.11M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $45.69M. Running result $45.69M. License: $17K. Product: $45.67M.
  • Cost of revenue: −$20.47M. Running result $25.22M.
  • Gross profit: $25.22M. Running result $25.22M.
  • Research and development expenses, net: −$27.9M. Running result −$2.68M.
  • Selling, general and administrative expenses: −$41.16M. Running result −$43.84M.
  • Operating income: −$43.84M. Running result −$43.84M.
  • Other income: $5.19M. Running result −$38.65M.
  • Pre-tax loss: −$38.65M. Running result −$38.65M.
  • Income tax expense: −$465K. Running result −$39.11M.
  • Net loss: −$39.11M. Running result −$39.11M.